Can we cut back on bladder drugs for seniors? new study aims to find out
NCT ID NCT06110975
First seen Jan 11, 2026 · Last updated Jun 23, 2026 · Updated 22 times
Summary
This study tests a guideline designed to help doctors safely reduce or stop overactive bladder medications in people aged 65 and older. Researchers will compare how many patients continue these drugs after six months between those whose doctors follow the guideline and those who receive usual care. The goal is to see if deprescribing can be done effectively in general practice without harming patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERACTIVE BLADDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aalborg University Hospital
Aalborg, Aalborg, 9000, Denmark
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
deprescribing guideline (procedure)
What this could lead to
If successful, this could provide a safe way to reduce unnecessary medications for overactive bladder in older adults, improving quality of life and reducing side effects.
What could go wrong
This is a small, early-stage study (72 participants) testing a process, not a new drug. The approach may not work for everyone or may not be adopted widely in practice.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.